Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis

ANK Therapeutic Prospects and Usefulness of PD-L1 and NK Activity as Biomarkers for Predicting Treatment Efficacy Revealed from the Treatment Course of Patients with HTLV-1-Associated Bronchioloalveolar Disease

Cancer Med J. 2023;6(1):30-36. Epub 2022 Sep 13. ABSTRACT Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell neoplasm with poor prognosis that can present as HTLV-1-associated bronchioloalveolar disease (HABA). Chemotherapy is recommended for ATL; however, it...
Generated by Feedzy